.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Joel Marcus
Joel MarcusALEXANDRIA VENTURE INVESTMENTS

Joel Marcus

Executive Chairman and Founder at ALEXANDRIA VENTURE INVESTMENTS

Investor

Deal Bio

Total Deals11
Valued Deals11
Total Value£2,955M
Avg. Deal Size£269M

Expertise (11)

Key Relationships

United States
Medical Services
Private EquityPrivateAcquisitionMinorityVenture Capital
INSITRO

target

INSITRO

Alexandria Venture Investments

bidder

Alexandria Venture Investments

£116m

38 dealmakers

United States
Biotechnology
Reverse TakeoverMergerAcquisitionDomesticPrivateDe-SPACPrivate Equity
HUMACYTE

target

HUMACYTE

Alpha Healthcare Acquisition

bidder

Alpha Healthcare Acquisition

£618m

48 dealmakers

United States
Biotechnology
MajorityAcquisitionVenture CapitalDomesticPrivate EquityPrivate
C2i Genomics

target

C2i Genomics

The Mark Foundation For Cancer Research

bidder

The Mark Foundation For Cancer Research

£72m

13 dealmakers

United States
Biotechnology
MinorityAcquisitionPrivate EquityPrivateVenture CapitalCross Border
Umoja Biopharma

target

Umoja Biopharma

Cormorant Asset Management

bidder

Cormorant Asset Management

£148m

14 dealmakers

United States
Biotechnology
PrivateMajorityAcquisitionPrivate EquityCross Border
Vividion Therapeutics

target

Vividion Therapeutics

Bayer

bidder

Bayer

£1,437m

47 dealmakers

Canada
Biotechnology
Venture CapitalMinorityPrivate EquityPrivateAcquisitionCross Border
Deep Genomics

target

Deep Genomics

True Ventures

bidder

True Ventures

£130m

12 dealmakers

United States
Biotechnology
Venture CapitalMinorityCross BorderPrivatePrivate EquityAcquisition
Lexeo Therapeutics

target

Lexeo Therapeutics

D1 Capital Partners

bidder

D1 Capital Partners

£72m

15 dealmakers

United States
Biotechnology
AcquisitionVenture CapitalCross BorderPrivatePrivate EquityMinority
Moma Therapeutics

target

Moma Therapeutics

Rock Springs Capital

bidder

Rock Springs Capital

£121m

14 dealmakers

United States
Biotechnology
MinorityVenture CapitalDomesticPrivatePrivate EquityAcquisition
Mozart Therapeutics

target

Mozart Therapeutics

Leaps By Bayer

bidder

Leaps By Bayer

£43m

9 dealmakers

United States
Biotechnology
AcquisitionVenture CapitalCross BorderPrivate EquityMinorityPrivate
Senda Biosciences

target

Senda Biosciences

Samsung Life

bidder

Samsung Life

£101m

11 dealmakers

France
Biotechnology
Venture CapitalPrivateAcquisitionPrivate EquityMinorityCross Border
Imcheck Therapeutics

target

Imcheck Therapeutics

Agent Capital

bidder

Agent Capital

£91m

17 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US